In this webinar, Dr. Thomas LeBlanc from Duke University Hospital discusses AML - how the diagnosis and treatment decisions impact patients. He provides a basic overview of AML and current treatments.
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Rare blood cancer and bone marrow failure diseases are often difficult to diagnose and even harder to explain. AAMDSIF brings international experts to your computer, tablet or smartphone using language that is easy to understand in a convenient one hour format. We have hundreds of webinars available for you to watch at any time you want!
Support for the 2023 AAMDSIF Webinar series is generously provided by Amgen, Apellis Pharmaceuticals, Merck & Co., and Taiho Oncology.
| Tue, 11/14/2023 - 2:00pm (EST) | Caregivers - Take Care but HOW???? |
|
| Tue, 11/21/2023 - 1:00pm (EST) | CCUS and MDS |
|
| Wed, 11/22/2023 - 11:00am (EST) | Cytopenia Management of Low Risk MDS |
|
| Wed, 11/29/2023 - 2:00pm (EST) | Living with PNH: Navigating Finances and Insurance |
|
| Mon, 12/11/2023 - 12:00pm (EST) | Integrative Medicine |
|
| Tue, 12/12/2023 - 2:00pm (EST) | Caregiver Panel - Let's Talk About Caring for Others |
|
In this webinar, Dr. Thomas LeBlanc from Duke University Hospital discusses AML - how the diagnosis and treatment decisions impact patients. He provides a basic overview of AML and current treatments.
Dr. Kasiani Myers of The Cancer and Blood Diseases Institute in Cincinnati, OH discusses the causes, diagnosis, and treatment of aplastic anemia and PNH. She will also discuss the relationship between aplastic anemia and PNH and how the dual diagnosis is treated.
In this webinar, Dr. Matt Kalaycio explains what is a bone marrow transplant and the risk and benefits of a transplant for MDS patients. Patients will be able to use the information learned in this webinar to have a discussion with their treating physician if a transplant is right for them.
During this program, Dr. Bhumika Patel and Dr. Jaroslaw Maciejewski from Taussig Cancer Institute discuss research reported over the past year on the biology and treatment of aplastic anemia and PNH. These studies were presented at the American Society of Hematology (ASH) 2018 meeting in San Diego, CA. Research findings are explained along with the potential impact of this research on understanding and treating aplastic anemia and PNH.
Updates from the December 2018 convening of the America Society of Hematology on MDS.
Joshua Sasine, MD, PhD discusses CAR-T cells and how they are used in transplant.
Dr. Steensma explains the relationship between Agent Orange and Myelodysplastic Syndromes in this webinar.
Recorded on October 16, 2018
Dr Navada explains how healthcare professionals diagnosis and treat the overlapping conditions of aplastic anemia and MDS, outlining the decisionmaking process and key factors relevant to effective treatment.
This webinar explains how myeloid malignancies form in plain language for patients and families.
This webinar provides the viewer with a basic understanding of myeloproliferative neoplasms (MPNs) as well as a review of how MPNs overlap with other bone marrow failure diseases, especially MDS.
Steven Devine, MD walks potential donors through all of the steps to becoming a bone marrow donor from screening to donation and everything in between. This webinar was a joint project between Be the Match and AAMDSIF.
Reducing the stress of diagnosis and treatment for rare bone marrow failure diseases is the topic of this webinar. K. Stolar explains in-depth in the full webinar, recorded 8-23-2018.
This webinar discusses the diagnosis and treatment options for pedaitric AML patients and their families.
Dr Mattison provides an overview of the two primary diagnosis tools for patients with MDS (myelodysplatic syndromes).
Dr Malone explains the key issues for transplant patients during the first 100 days, focusing on Acute GVHD (graft-versus-host-disease).
Dr Foran explains how blood transfusions are used for bone marrow failure disease patients and how hematologists/oncologists deal with iron overload.
A look to the future of treatment for patients with PNH (paroxysmal nocturnal hemoglobinuria).
Dr DeZern provides a thorough review of the three major classificiations of aplastic anemia including diagnosis, treatment and prognosis.
Dr Michael Pulsipher discusses the cognitive, social and physical side effects for children dealing with bone marrow failure diseases.
Dr Savona explains what options are available for patients with AML outside of transplant.
